Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118


Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.

Wu CC, Crain B, Yao S, Sabet M, Lao FS, Tawatao RI, Chan M, Smee DF, Julander JG, Cottam HB, Guiney DG, Corr M, Carson DA, Hayashi T.

J Innate Immun. 2014;6(3):315-24. doi: 10.1159/000355217. Epub 2013 Nov 1.


Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.

Goff PH, Hayashi T, Martínez-Gil L, Corr M, Crain B, Yao S, Cottam HB, Chan M, Ramos I, Eggink D, Heshmati M, Krammer F, Messer K, Pu M, Fernandez-Sesma A, Palese P, Carson DA.

J Virol. 2015 Mar;89(6):3221-35. doi: 10.1128/JVI.03337-14. Epub 2015 Jan 7.


Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.

Konopka JL, Thompson JM, Whitmore AC, Webb DL, Johnston RE.

J Virol. 2009 Dec;83(23):12432-42. doi: 10.1128/JVI.00564-09. Epub 2009 Sep 30.


Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection.

Ho LP, Denney L, Luhn K, Teoh D, Clelland C, McMichael AJ.

Eur J Immunol. 2008 Jul;38(7):1913-22. doi: 10.1002/eji.200738017.


Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.

Hayashi T, Yao S, Crain B, Chan M, Tawatao RI, Gray C, Vuong L, Lao F, Cottam HB, Carson DA, Corr M.

PLoS One. 2012;7(9):e45860. doi: 10.1371/journal.pone.0045860. Epub 2012 Sep 28.


Impaired immune responses in the lungs of aged mice following influenza infection.

Toapanta FR, Ross TM.

Respir Res. 2009 Nov 18;10:112. doi: 10.1186/1465-9921-10-112.


Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.

Reppe K, Radünzel P, Dietert K, Tschernig T, Wolff T, Hammerschmidt S, Gruber AD, Suttorp N, Witzenrath M.

Infect Immun. 2015 Dec;83(12):4617-29. doi: 10.1128/IAI.00948-15. Epub 2015 Sep 14.


Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.

Norton EB, Clements JD, Voss TG, Cárdenas-Freytag L.

J Virol. 2010 Mar;84(6):2983-95. doi: 10.1128/JVI.01805-09. Epub 2010 Jan 6.


Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.

Shinchi H, Crain B, Yao S, Chan M, Zhang SS, Ahmadiiveli A, Suda Y, Hayashi T, Cottam HB, Carson DA.

Bioconjug Chem. 2015 Aug 19;26(8):1713-23. doi: 10.1021/acs.bioconjchem.5b00285. Epub 2015 Aug 5.


Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.

Wong EB, Mallet JF, Duarte J, Matar C, Ritz BW.

Nutr Res. 2014 Apr;34(4):318-25. doi: 10.1016/j.nutres.2014.02.007. Epub 2014 Mar 6.


Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.

Hayashi T, Chan M, Norton JT, Wu CC, Yao S, Cottam HB, Tawatao RI, Corr M, Carson DA, Daniels GA.

Melanoma Res. 2011 Feb;21(1):66-75. doi: 10.1097/CMR.0b013e328340ce6c.


Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.

Hammerbeck DM, Burleson GR, Schuller CJ, Vasilakos JP, Tomai M, Egging E, Cochran FR, Woulfe S, Miller RL.

Antiviral Res. 2007 Jan;73(1):1-11. Epub 2006 Aug 18.


Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.

Shi X, Zhou W, Huang H, Zhu H, Zhou P, Zhu H, Ju D.

Crit Care. 2013 Dec 27;17(6):R301. doi: 10.1186/cc13171.


MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection.

Seo SU, Kwon HJ, Song JH, Byun YH, Seong BL, Kawai T, Akira S, Kweon MN.

J Virol. 2010 Dec;84(24):12713-22. doi: 10.1128/JVI.01675-10. Epub 2010 Oct 13.


Ecto-5'-nucleotidase CD73 modulates the innate immune response to influenza infection but is not required for development of influenza-induced acute lung injury.

Aeffner F, Woods PS, Davis IC.

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 1;309(11):L1313-22. doi: 10.1152/ajplung.00130.2015. Epub 2015 Oct 2.


Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.

Ichinohe T, Nagata N, Strong P, Tamura S, Takahashi H, Ninomiya A, Imai M, Odagiri T, Tashiro M, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H.

J Med Virol. 2007 Jun;79(6):811-9.


Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.

Zhang AJ, Li C, To KK, Zhu HS, Lee AC, Li CG, Chan JF, Hung IF, Yuen KY.

Clin Vaccine Immunol. 2014 Apr;21(4):570-9. doi: 10.1128/CVI.00816-13. Epub 2014 Feb 12.


Human lung innate immune response to Bacillus anthracis spore infection.

Chakrabarty K, Wu W, Booth JL, Duggan ES, Nagle NN, Coggeshall KM, Metcalf JP.

Infect Immun. 2007 Aug;75(8):3729-38. Epub 2007 May 21.

Items per page

Supplemental Content

Support Center